0001493152-26-006698
SEC filingPicoCELA Inc. reported total revenue of $544.7 million for the fiscal year ended September 30, 2025. Despite generating revenue, the company incurred a substantial operating loss of $601.4 million, driven primarily by selling, general, and administrative expenses of $892.0 million. The net loss for the period was $626.3 million, resulting in a basic and diluted loss per share of $683. The company maintains a liquidity position with $534.9 million in cash and cash equivalents and total shareholders' equity of $469.9 million. Financing activities provided significant cash infusions, including $1.24 billion from common shares issuance and $852.1 million from class C preferred shares issuance, offsetting the $544.0 million used in operating activities. The balance sheet reflects total assets of $1.09 billion against total liabilities of $617.2 million. No prior year comparative figures were provided in the XBRL data, limiting year-over-year performance analysis.
PicoCELA Inc. reported total revenue of $544.7 million for the fiscal year ended September 30, 2025. The cost of revenue was $254.1 million, resulting in a gross profit of $290.6 million. However, the company faced significant operational challenges, reporting an operating loss of $601.4 million. This loss was primarily driven by selling, general, and administrative expenses of $892.0 million. Consequently, the net loss for the year was $626.3 million. Basic and diluted loss per share stood at $683. The weighted average shares outstanding were 917,000. No prior year comparative data was available in the provided XBRL financial data to assess year-over-year trends.
The XBRL data provided does not contain a breakdown of revenue by segment, geography, or product line. Total revenue is reported as a single line item of $544.7 million. Without segment disclosures or MD&A commentary in the source text, specific growth drivers or revenue mix analysis cannot be determined. The revenue figure stands alone without comparative context from the previous fiscal year.
The company reported a gross margin of approximately 53.3%, calculated from revenue of $544.7 million and cost of revenue of $254.1 million. Despite the positive gross margin, the company's cost structure, particularly the $892.0 million in SG&A expenses, resulted in a negative operating margin of -110.4%. Other expenses, including interest expense of $17.4 million and foreign exchange losses of $8.6 million, further pressured the bottom line, widening the net loss margin.
Net cash used in operating activities was $544.0 million. Capital expenditures totaled $46.0 million ($28.3M in property/equipment and $17.7M in intangibles), resulting in a free cash outflow of approximately $572.3 million (operating cash flow minus capital expenditures). Financing activities provided a net $668.1 million, largely from proceeds of $1.24 billion (common shares) and $852.1 million (preferred shares), offset by $299.5 million in deferred offering costs. The company holds $534.9 million in cash and total liabilities of $617.2 million, including $300.0 million in bonds payable and $261.9 million in current borrowings.
The provided document text and XBRL data do not contain forward-looking statements, management guidance, or strategic priorities regarding future operations. Consequently, an assessment of the company's future outlook or risk factors based on the current filing content is not possible. Investors should refer to the complete 20-F filing for MD&A and risk factor disclosures.